Emily Letton | News Reporter

Articles and archive:

Analysis | Cell & Gene Therapy | Contamination Control | Design & Build | Digital | Distribution | Dosage Forms | Drug Delivery | Finance | Finished Product | Hi Tech Manufacturing | Ingredients | Logistics | Manufacturing | Marketing | Media | Microbiology | Packaging | Pharma 5.0 | Pharmaceutical | Regulatory | Research & Development | Sustainability | Training & Education

Emily covers the ever-changing pharma landscape and innovative ingredients from the supplement sector, with particular interest in sports nutrition and the policies and regulations shaping the market

Emily Letton

Profile

Emily is the Scientific Reporter for Nutraceutical Business Review and Manufacturing Chemist. Emily has a background in Biomedical Science and Genetics and a Master’s degree in Journalism from Oxford Brookes University. When she’s not reporting on the latest news, you'll find her in a boat on the river.

 

Related content

Regulatory
Johnson & Johnson secures FDA approval for RYBREVANT FASPRO in head and neck cancer

Johnson & Johnson secures FDA approval for RYBREVANT FASPRO in head and neck cancer

The accelerated approval marks the first expansion of J&J's dual-targeted cancer therapy beyond lung cancer, with the subcutaneous treatment demonstrating a 42% response rate in a Phase Ib/II trial
Finance
Dipharma acquires LogixX Pharma to expand UK pharmaceutical presence

Dipharma acquires LogixX Pharma to expand UK pharmaceutical presence

Dipharma has acquired UK-based LogixX Pharma, establishing a direct commercial presence in the UK and creating a platform for future launches of medicines targeting rare and metabolic diseases
Media
Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

The company has been recognised for its end-to-end digital capabilities, AI-enabled portfolio and open Smart Lab Ecosystem in IDC’s 2026 assessment of life sciences R&D technology providers, with case studies from GSK and AstraZeneca highlighting the potential of digital twins and process modelling to accelerate development and manufacturing
Finance
Viral vector CDMO VintaBio’s Philadelphia facility and IP up for sale

Viral vector CDMO VintaBio’s Philadelphia facility and IP up for sale

VintaBio’s assignee is seeking bids for its cGMP facility, equipment and proprietary AAV technology as gene therapy contract manufacturers face overcapacity
Ingredients
UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals
Manufacturing
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India

The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
Pharmaceutical
OGT launches four IVDR-certified CytoCell FISH probes for haematological malignancy diagnostics

OGT launches four IVDR-certified CytoCell FISH probes for haematological malignancy diagnostics

The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, helping laboratories maintain compliant leukaemia and myeloma testing workflows
Finance
Merck KGaA divests US CDMO business to Lonza

Merck KGaA divests US CDMO business to Lonza

Merck KGaA will sell its US CDMO business to Lonza in a deal worth hundreds of millions of Swiss francs, expanding Lonza's US manufacturing footprint and marking a strategic shift for Merck
Manufacturing
Pace Life Sciences completes EMA GMP inspection at New Jersey CDMO facility

Pace Life Sciences completes EMA GMP inspection at New Jersey CDMO facility

The inspection supports renewal of the EU GMP certificate at the company's New Jersey site, which provides pharmaceutical analytical testing, microbiology and development services
Pharmaceutical
Bavarian Nordic secures four-year UK vaccine supply contract

Bavarian Nordic secures four-year UK vaccine supply contract

The agreement with the UK Health Security Agency will see the Danish vaccine manufacturer supply its MVA-BN mpox and smallpox vaccine, supporting the UK's long-term infectious disease preparedness
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
UK Budget 2026: what it means for pharma manufacturing

UK Budget 2026: what it means for pharma manufacturing

VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but gaps remain
Manufacturing
ESTEVE CDMO invests $80m in new China API manufacturing site

ESTEVE CDMO invests $80m in new China API manufacturing site

The Shaoxing facility will provide 250 m³ of reaction volume, with potential capacity exceeding 400 m³, as the CDMO expands its global small-molecule API manufacturing network